Byung-Jhip Ha

Title: Byung-Jhip Ha: Innovator in Ophthalmic Pharmaceutical Composition

Introduction

Byung-Jhip Ha is a notable inventor based in Icheon, South Korea. He has made significant contributions to the field of ophthalmic pharmaceuticals. His work focuses on developing compositions that enhance the efficacy and stability of treatments.

Latest Patents

One of his key patents is for an ophthalmic pharmaceutical composition that includes aflibercept as an active ingredient. This composition is designed to maintain a specific pH and includes an acetate salt buffering agent. Notably, it is free of ionic tonicity agents, which helps to remarkably reduce the formation of dimeric and multimeric impurities. This innovation ensures that the biological activity remains high for extended periods, even under accelerated stress conditions and cold storage.

Career Highlights

Byung-Jhip Ha is currently associated with Sam Chun Dang Pharm. Co., Ltd. His work at this company has been instrumental in advancing ophthalmic treatments. He has demonstrated a commitment to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

He has collaborated with talented coworkers, including Yong-Seop Park and Na-Won Park. Their combined expertise contributes to the success of their projects and the development of effective pharmaceutical compositions.

Conclusion

Byung-Jhip Ha's contributions to ophthalmic pharmaceuticals highlight his innovative spirit and dedication to improving healthcare. His patent for an aflibercept ophthalmic composition exemplifies the potential for advancements in this critical field.